SIRT1 histone deacetylase is a potential therapeutic target for human melanoma

被引：0
|
作者：
Nihal, M. [1 ]
Singh, C. K. [1 ]
Ndiaye, M. [1 ]
Wood, G. S. [1 ]
Ahmad, N. [1 ]
机构：
[1] Univ Wisconsin, Madison, WI 53706 USA
来源：
PIGMENT CELL & MELANOMA RESEARCH | 2011年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：857 / 858
页数：2
相关论文
共 50 条
  • [31] Histone Deacetylase SIRT1, Smooth Muscle Cell Function, and Vascular Diseases
    Wang, Fang
    Chen, Hou-Zao
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [32] Therapeutic potential of histone deacetylase inhibitors in human liposarcomas
    Muhlenberg, Thomas
    Pedeutour, Florence
    Fletcher, Jonathan A.
    Schuler, Martin
    Bauer, Sebastian
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [33] Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors
    Therrien, Eric
    Larouche, Guillaume
    Nguyen, Natalie
    Rahil, Jubrail
    Lemieux, Anne-Marie
    Li, Zuomei
    Fournel, Marielle
    Yan, Theresa P.
    Landry, Anne-Julie
    Lefebvre, Sylvain
    Wang, James J.
    MacBeth, Kyle
    Heise, Carla
    Nguyen, Aaron
    Besterman, Jeffrey M.
    Deziel, Robert
    Wahhab, Amal
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (12) : 2514 - 2518
  • [34] SIRT1: a potential therapeutic target for coronary heart disease combined with anxiety or depression
    Yu, Hubin
    Li, Xinping
    Ning, Bo
    Feng, Lanshuan
    Ren, Yaolong
    Li, Shilin
    Kang, Yalong
    Ma, Jing
    Zhao, Mingjun
    JOURNAL OF DRUG TARGETING, 2025, 33 (03) : 328 - 340
  • [35] Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer A TARGET FOR PROSTATE CANCER MANAGEMENT VIA ITS INHIBITION?
    Jung-Hynes, Brittney
    Nihal, Minakshi
    Zhong, Weixiong
    Ahmad, Nihal
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (06) : 3823 - 3832
  • [36] A Class 1 Histone Deacetylase with Potential as an Antifungal Target
    Bauer, Ingo
    Varadarajan, Divyavaradhi
    Pidroni, Angelo
    Gross, Silke
    Vergeiner, Stefan
    Faber, Birgit
    Hermann, Martin
    Tribus, Martin
    Brosch, Gerald
    Graessle, Stefan
    MBIO, 2016, 7 (06):
  • [37] Histone deacetylase III as a potential therapeutic target for the treatment of lethal sepsis
    Zhao, Ting
    Li, Yongqing
    Liu, Baoling
    Bronson, Roderick T.
    Halaweish, Ihab
    Alam, Hasan B.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 77 (06): : 913 - 919
  • [38] Histone deacetylase 2: A potential therapeutic target for cancer and neurodegenerative disorders
    Gediya, Piyush
    Parikh, Palak K.
    Vyas, Vivek K.
    Ghate, Manjunath D.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 216
  • [39] Histone Deacetylase SIRT1 Targets Plk2 to Regulate Centriole Duplication
    Ling, Hongbo
    Peng, Lirong
    Wang, Jianbo
    Rahhal, Raneen
    Seto, Edward
    CELL REPORTS, 2018, 25 (10): : 2851 - +
  • [40] Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma
    Jang, Si-Hyong
    Min, Kyeung-Whan
    Paik, Seung Sam
    Jang, Ki-Seok
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (08) : 735 - 739
12345